[Prevention of early inflammatory complications after transthoracic interventions and estimation of the degree of immunologic deficiency].
An analysis of the results of the examination and treatment of 379 patients undergoing transthoracic interventions showed that the use of the target-aimed selective immunomodulation, short-term antibacterial prophylaxis, inhibitors of arachidonic acid metabolites, active elimination of the circulating immune complexes and medium-weight molecular peptides and adequate local analgesia after the interventions providing normalization of the laryngeal reflex and early activation of the patients permitted the incidence of the pulmonary complications to be decreased by 2.5 times, pleural complications by 1.7 times, suppuration of the postoperative wound by 1.8 times and the total expenses by 25.6 per cent.
Radomskiĭ
V T
VT
Bondarev
V I
VI
Iakovleva
I M
IM
Ablitsov
N P
NP
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D016724:Empyema, Pleural / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007958:Leukocyte Count; D008169:Lung Abscess / Q000209:etiology / Q000517:prevention & control*; D008171:Lung Diseases / Q000276:immunology / Q000601:surgery*; D008231:Lymphopenia / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D013530:Surgical Wound Infection / Q000209:etiology / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D013997:Time Factors
D000276:Adjuvants, Immunologic
Profilaktika rannikh vospalitel'nykh oslozhneniĭ posle trans- torakal'nykh vmeshatel'stv s uchetom vyrazhennosti immunodefitsita.